GGDPX
Price
$15.38
Change
+$0.09 (+0.59%)
Updated
Jun 27 closing price
Net Assets
5.1B
GIRLX
Price
$15.27
Change
+$0.09 (+0.59%)
Updated
Jun 27 closing price
Net Assets
5.1B
Interact to see
Advertisement

GGDPX vs GIRLX

Header iconGGDPX vs GIRLX Comparison
Open Charts GGDPX vs GIRLXBanner chart's image
Goldman Sachs Intl Sm Cp Insghts P
Price$15.38
Change+$0.09 (+0.59%)
VolumeN/A
Net Assets5.1B
Goldman Sachs Intl Sm Cp Insghts I
Price$15.27
Change+$0.09 (+0.59%)
VolumeN/A
Net Assets5.1B
GGDPX vs GIRLX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GGDPX vs. GIRLX commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GGDPX is a Buy and GIRLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GGDPX (5.1B) and GIRLX (5.1B) have equal amount of cash in the bank . GGDPX (3.94) and GIRLX (3.87) have matching dividends . GGDPX was incepted earlier than GIRLX: GGDPX (7 years) vs GIRLX (15 years). GIRLX (1.02) is less costly to investors than GGDPX (0.90). GGDPX (165.00) and GIRLX (165.00) have comparable annual turnover. GGDPX (0) and GIRLX (0) have matching initial minimum investment requirements. GGDPX (25.72) and GIRLX (25.50) have marching annual gain over last year. GGDPX return over 5 years is better than : 74.31 vs. GIRLX (70.58).
GGDPXGIRLXGGDPX / GIRLX
Total Expense Ratio0.850.9788%
Annual Report Gross Expense Ratio0.901.0288%
Fund Existence7 years15 years-
Gain YTD25.14224.959101%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets5.1B5.1B100%
Annual Yield % from dividends3.943.87102%
Returns for 1 year25.7225.50101%
Returns for 3 years54.9454.28101%
Returns for 5 years74.3170.58105%
Returns for 10 yearsN/A81.89-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRT127.163.36
+2.71%
Vertiv Holdings Co
RYTM62.731.28
+2.09%
Rhythm Pharmaceuticals
HTCR0.53N/A
N/A
Heartcore Enterprises
EFC12.98-0.16
-1.22%
Ellington Financial
TVRD24.61-0.60
-2.38%
Tvardi Therapeutics Inc